Clinical Trial TitleColchicine coronavirus SARS-CoV2 trial.
Clinical Trial Protocol Description:
This study is to determine whether short-term treatment with colchicine reduces the rate of death and lung complications related to COVID-19.
Clinical Trial Eligibility Criteria:
In order to participate you must meet the following criteria:
- Are male or female, at least 40 years of age.
- Have received diagnosis of COVID-19 infection within the last 24 hours.
You will be excluded from the study if any of the following criteria apply to you:
- Are currently hospitalized or under immediate consideration for hospitalization.
This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.